PRESS RELEASE published on 08/28/2025 at 07:29, 1 year 1 month ago Q2 and H1 2025 financial results: Delivery Hero accelerates growth and expands profitability, updates full-year guidance Delivery Hero SE reports accelerated growth and enhanced profitability in Q2 and H1 2025 financial results, updating full-year guidance. Company demonstrates strong operational performance and robust financial position Financial Results Delivery Hero Full-year Guidance Q2 2025 H1 2025
PRESS RELEASE published on 08/28/2025 at 07:16, 1 year 1 month ago Adler Group S.A. announces results for H1 2025 demonstrating strong performance in the rental business Adler Group S.A. announces strong H1 2025 results with 3.4% like-for-like rental growth and €285m cash position. Focus on Berlin residential portfolio Financial Performance Adler Group S.A. Rental Business Berlin Portfolio H1 2025 Results
PRESS RELEASE published on 08/28/2025 at 07:10, 1 year 1 month ago EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth Revenues EBIT EDAG Engineering Group AG Defence Activities Market Restraint
PRESS RELEASE published on 08/28/2025 at 07:02, 1 year 1 month ago Press release: Leonteq expands market presence with leverage products on BX Swiss Leonteq expands market presence with leverage products on BX Swiss, launching over 5,000 products with leading execution quality and strategic growth plans Switzerland Leonteq BX Swiss Market Presence Leverage Products
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago SoftwareOne reports revenue decline and improved margin as expected in H1 2025; Crayon integration on track SoftwareOne Holding AG reports revenue decline and improved margin in H1 2025, including Crayon integration progress. Company outlook focuses on growth and synergy achievements Revenue Decline SoftwareOne Margin Improvement H1 2025 Crayon Integration
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Positive development across all major KPI: STRABAG on track for profitable growth STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth Profitable Growth STRABAG SE EBIT Growth First Half 2025 Results Output Increase
REGULATED PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals Biophytis Sarcopenia Phase 3 EMA Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Exail strengthens its position in the surface drone sector with the first sale of a new long-range DriX drone model Exail Technologies announces the sale of the DriX H-9, expanding its autonomous surface drone solutions for civil and defense markets. The H-9 offers enhanced capabilities for maritime missions Exail Technologies Defense Applications Autonomous Drones DriX H-9 Maritime Missions
PRESS RELEASE published on 08/28/2025 at 06:59, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
Published on 10/20/2026 at 11:30, 12 minutes ago GGL Resources Corp. and Strategic Metals Ltd. Property Transaction Approved
Published on 10/20/2026 at 11:00, 42 minutes ago Silver Range Resources Ltd. Appoints Luke Schranz Vice President
Published on 10/20/2026 at 09:01, 2 hours 41 minutes ago Discovery Energy Metals Corp. Samples 197 g/t Ag and 0.26% Cu in Outcrop at Crystal Lake Project, British Columbia
Published on 10/19/2026 at 23:20, 12 hours 22 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/20/2026 at 11:30, 11 minutes ago Correction of a release from 20/10/2026, 10:34 CET/CEST - Branicks Group AG: Creditors Vote to Extend Maturity and Pave the Way for Restructuring
Published on 10/20/2026 at 11:15, 27 minutes ago Coinsilium Group Limited: Coinsilium Strategic Update: Project Developments, Growth Priorities and Outlook into 2027
Published on 10/20/2026 at 11:05, 37 minutes ago MARSTEK Unveils VENUS E Pro, the Smarter Plug-in Battery Powered by MARSTEK Intelligence
Published on 10/20/2026 at 10:35, 1 hour 7 minutes ago Office DOOH is not standard DOOH: Lumen study finds ECN screens earn 3.4x more attention than comparable digital out-of-home
Published on 10/20/2026 at 10:34, 1 hour 8 minutes ago Branicks Group AG: Creditors Vote to Extend Maturity and Pave the Way for Restructuring
Published on 10/20/2026 at 10:17, 1 hour 24 minutes ago Statement of transactions in own shares from October 12, 2026 to October 16, 2026
Published on 10/20/2026 at 07:45, 3 hours 57 minutes ago Schneider Electric announces the success of its €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
Published on 10/19/2026 at 18:40, 17 hours 2 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 17 hours 42 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response